Jeff Zahn and David Shreiber received a $111,289 grant from the NIH funded Point of Care Center for Emerging Technologies at the University of Cincinnati to develop microdevices for monitoring inflammation in the CSF and allowing localized drug delivery following spinal cord injuries.